| Title : Variants of carboxylesterase 1 have no impact on capecitabine pharmacokinetics and toxicity in capecitabine plus oxaliplatin treated-colorectal cancer patients - Matsumoto_2020_Cancer.Chemother.Pharmacol__ |
| Author(s) : Matsumoto N , Kubota Y , Ishida H , Sekido M , Ohkuma R , Ishiguro T , Hirasawa Y , Ariizumi H , Tsunoda T , Ikusue T , Kobayashi K , Hisamatsu A , Toshima H , Shimada K , Fujita KI |
| Ref : Cancer Chemother Pharmacol , : , 2020 |
| Abstract : Matsumoto_2020_Cancer.Chemother.Pharmacol__ |
| ESTHER : Matsumoto_2020_Cancer.Chemother.Pharmacol__ |
| PubMedSearch : Matsumoto_2020_Cancer.Chemother.Pharmacol__ |
| PubMedID: 32458030 |
Matsumoto N, Kubota Y, Ishida H, Sekido M, Ohkuma R, Ishiguro T, Hirasawa Y, Ariizumi H, Tsunoda T, Ikusue T, Kobayashi K, Hisamatsu A, Toshima H, Shimada K, Fujita KI (2020)
Variants of carboxylesterase 1 have no impact on capecitabine pharmacokinetics and toxicity in capecitabine plus oxaliplatin treated-colorectal cancer patients
Cancer Chemother Pharmacol
:
Matsumoto N, Kubota Y, Ishida H, Sekido M, Ohkuma R, Ishiguro T, Hirasawa Y, Ariizumi H, Tsunoda T, Ikusue T, Kobayashi K, Hisamatsu A, Toshima H, Shimada K, Fujita KI (2020)
Cancer Chemother Pharmacol
: